These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24137709)

  • 1. Response.
    Davenport MS; Liu PS; Chenevert TL; Hussain HK
    Radiology; 2013 Sep; 268(3):927. PubMed ID: 24137709
    [No Abstract]   [Full Text] [Related]  

  • 2. Does intravenous administration of gadoxetate disodium have any effect on breath-hold times.
    Bergmann K; Agris J; Balzer T
    Radiology; 2013 Sep; 268(3):926-7. PubMed ID: 23970514
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
    Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
    Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can gadopentetate dimeglumine be safely administered more rapidly than the FDA-approved injection rate for liver imaging?
    Shiehmorteza M; Hanna RF; Middleton MS
    AJR Am J Roentgenol; 2007 Oct; 189(4):W231. PubMed ID: 17885038
    [No Abstract]   [Full Text] [Related]  

  • 5. Gadoxetic acid-induced acute transient dyspnea: the perspective of Japanese radiologists.
    Motosugi U
    Magn Reson Med Sci; 2015; 14(2):163-4. PubMed ID: 25740243
    [No Abstract]   [Full Text] [Related]  

  • 6. A word of caution on the use of high-dose MR contrast media in patients with renal failure.
    Geckeis K; Eggebrecht H; Quick HH; Barkhausen J; Kribben A; Erbel R
    J Endovasc Ther; 2005 Apr; 12(2):262. PubMed ID: 15823076
    [No Abstract]   [Full Text] [Related]  

  • 7. Seizure after gadolinium administration.
    Hailemeskal B; Ilogu E; Khuc K; Curry C; Kelvas M
    Radiol Technol; 1999; 70(4):387. PubMed ID: 10101755
    [No Abstract]   [Full Text] [Related]  

  • 8. An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging.
    Motosugi U; Bannas P; Bookwalter CA; Sano K; Reeder SB
    Radiology; 2016 Apr; 279(1):93-102. PubMed ID: 26473642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast agent approved for liver imaging.
    Thompson CA
    Am J Health Syst Pharm; 2008 Aug; 65(16):1490. PubMed ID: 18693195
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?
    Thomsen HS; Marckmann P; Logager VB
    Acta Radiol; 2007 Jul; 48(6):593-6. PubMed ID: 17611863
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of Eovist in Pediatric Patients: Pearls and Pitfalls.
    Shet NS; Flynn JF; Maloney E; Iyer RS
    Curr Probl Diagn Radiol; 2020; 49(4):266-274. PubMed ID: 31047739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial.
    Wolansky LJ; Haghighi MH; Sevdalis E; Cook SD; Sethi N; Liu J; Joseph G; Tulloch K; Cadavid D
    J Neuroimaging; 2005 Jul; 15(3):289-90. PubMed ID: 15951416
    [No Abstract]   [Full Text] [Related]  

  • 13. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac arrest caused by IV gadopentetate dimeglumine.
    Unal O; Arslan H
    AJR Am J Roentgenol; 1999 Apr; 172(4):1141. PubMed ID: 10587169
    [No Abstract]   [Full Text] [Related]  

  • 15. Inadvertent intraosseous gadolinium injection during pediatric shoulder MR arthrography.
    Pack JR; Jordanov MI; Block JJ
    Pediatr Radiol; 2008 Jul; 38(7):772-5. PubMed ID: 18414840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Arterial Phase in Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging: Analysis of Respiratory Patterns and Their Effect on Image Quality.
    Park YS; Lee CH; Yoo JL; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM
    Invest Radiol; 2016 Feb; 51(2):127-33. PubMed ID: 26418367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for radiologists' awareness of nephrogenic systemic fibrosis.
    Aydingöz U
    Diagn Interv Radiol; 2006 Dec; 12(4):161-2. PubMed ID: 17160795
    [No Abstract]   [Full Text] [Related]  

  • 18. Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan).
    Decupere M; Ooms V; Oyen R; Kuypers DR; Claes K
    Nephrol Dial Transplant; 2005 Jul; 20(7):1516-7. PubMed ID: 15886213
    [No Abstract]   [Full Text] [Related]  

  • 19. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notes on "Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent".
    Runge VM
    AJR Am J Roentgenol; 2008 Jun; 190(6):1433-4. PubMed ID: 18492887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.